The Effect of Anti-epileptic Drugs on Mitochondrial Activity
Completed
- Conditions
- Epilepsy
- Interventions
- Biological: antiepileptic treatment
- First Posted Date
- 2010-10-11
- Last Posted Date
- 2018-03-06
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 60
- Registration Number
- NCT01218321
- Locations
- 🇮🇱
Hadassah-Hebrew University Medical Center, Jerusalem, Israel
Human Chorionic Gonadotropin Supplementation Prior to In-vitro Fertilization Treatment in Poor Responders
- First Posted Date
- 2010-09-20
- Last Posted Date
- 2011-03-02
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 100
- Registration Number
- NCT01205009
- Locations
- 🇮🇱
Hadassah Medical Center, Jerusalem, Israel
¹³C-Methacetin Breath Test (MBT) Methodology Study
Phase 2
- Conditions
- Healthy SubjectsChronic Liver DiseaseCirrhosis
- Interventions
- Device: 13C Methacetin Breath TestDietary Supplement: Grape fruit juiceDrug: Non selective beta blocker - PropranololDietary Supplement: Ethanol
- First Posted Date
- 2010-09-20
- Last Posted Date
- 2012-08-28
- Lead Sponsor
- Hadassah Medical Organization
- Registration Number
- NCT01205074
- Locations
- 🇮🇱
Liver Unit Hadassah Medical Center, Jerusalem, Israel
Safety and Efficacy of Oral Administration of Anti-CD3 Monoclonal Antibody (mAb)in Patients With the Metabolic Syndrome
- First Posted Date
- 2010-09-20
- Last Posted Date
- 2011-06-23
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 36
- Registration Number
- NCT01205087
- Locations
- 🇮🇱
Hadassah University Hospital, Liver Unit, Jerusalem, Israel
Follow Up of Patients Chronic Hepatitis B (CHB) Treated With Sebivo Using the 13C Methacetin Breath Test
Phase 2
Withdrawn
- Conditions
- Chronic Hepatitis B
- Interventions
- Device: 13C Methacetin Breath Test (BreathID)
- First Posted Date
- 2010-09-17
- Last Posted Date
- 2012-08-28
- Lead Sponsor
- Hadassah Medical Organization
- Registration Number
- NCT01204827
- Locations
- 🇮🇱
Liver Unit, Hadassah Hebrew University Medical Center, Jerusalem, Israel
Evaluation of A-1 Cool Cream Efficacy for Treatment Atopic Dermatitis
Phase 1
- Conditions
- ATOPIC DERMATITIS
- Interventions
- Drug: A -1 Cool Cream,Vaselin ointment
- First Posted Date
- 2010-08-03
- Last Posted Date
- 2011-07-06
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 30
- Registration Number
- NCT01174511
New Castle Disease Virus (NDV) in Glioblastoma Multiforme (GBM), Sarcoma and Neuroblastoma
Phase 1
Withdrawn
- Conditions
- GlioblastomaSarcomaNeuroblastoma
- First Posted Date
- 2010-08-03
- Last Posted Date
- 2015-06-11
- Lead Sponsor
- Hadassah Medical Organization
- Registration Number
- NCT01174537
- Locations
- 🇮🇱
Hadassah Medical Organization, Jerusalem, Israel
Evaluation of Surgical Complications
Not Applicable
Completed
- Conditions
- Post Operative Complications
- Interventions
- Other: No intervention
- First Posted Date
- 2010-07-23
- Last Posted Date
- 2013-09-25
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 2200
- Registration Number
- NCT01168193
A Clinical Study: the Antibacterial Effect of Insoluble Antibacterial Nanoparticles (IABN) Incorporated in Dental Materials for Root Canal Treatment
Phase 2
- Conditions
- Endodontic TreatmentIrreversible PulpitisHealth PulpInfected Pulp
- Interventions
- Device: IABN
- First Posted Date
- 2010-07-22
- Last Posted Date
- 2013-07-23
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 200
- Registration Number
- NCT01167985
- Locations
- 🇮🇱
Hadassah Medical Organization, Jerusalem, Israel
Early Diagnosis of Malignant Transformation of Pigmentary Skin Lesions
- Conditions
- Skin NeoplasmMalignant MelanomaPigmented Nevi
- First Posted Date
- 2010-07-22
- Last Posted Date
- 2018-08-02
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 20
- Registration Number
- NCT01167998
- Locations
- 🇮🇱
: Hadassah Medical Organization,, Jerusalem, Israel
© Copyright 2025. All Rights Reserved by MedPath